Literature DB >> 17108201

Use of bi-allelic insertion/deletion polymorphisms as a positive control for fetal genotyping in maternal blood: first clinical experience.

Godelieve C M L Page-Christiaens1, Bernadette Bossers, C Ellen VAN DER Schoot, Masja DE Haas.   

Abstract

Amplification of fetal DNA in maternal plasma is a new way for non-invasive fetal genotyping in pregnancies at risk for disorders where the presence of a paternal DNA sequence contributes to the risk status of the fetus. We describe the use of a panel of 10 bi-allelic highly polymorphic markers to ascertain the presence and amplification of fetal DNA in case the fetus is negative for the targeted paternal "disease" sequence.

Mesh：

Substances：

Year:  2006        PMID： 17108201     DOI： 10.1196/annals.1368.016

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


  9 in total

1.  The Glass Slide Extraction System Snap Card Improves Non-Invasive Prenatal Genotyping in Pregnancies with Antibodies.

Authors:  Thomasz Adamczyk; Andrea Doescher; Paul V Haydock; Russ Aldrich; Eduard K Petershofen; Thomas H Müller
Journal:  Transfus Med Hemother       Date:  2015-10-26       Impact factor: 3.747

2.  Prenatal RhD Testing: A Review of Studies Published from 2006 to 2008.

Authors:  Tobias Jörg Legler; Sina Patricia Müller; Alexander Haverkamp; Simon Grill; Sinuhe Hahn
Journal:  Transfus Med Hemother       Date:  2009-05-14       Impact factor: 3.747

Review 3.  The molecular genetics of blood group polymorphism.

Authors:  Geoff Daniels
Journal:  Hum Genet       Date:  2009-08-29       Impact factor: 4.132

4.  Evaluation of a novel assay for detection of the fetal marker RASSF1A: facilitating improved diagnostic reliability of noninvasive prenatal diagnosis.

Authors:  Helen E White; Carolyn L Dent; Victoria J Hall; John A Crolla; Lyn S Chitty
Journal:  PLoS One       Date:  2012-09-14       Impact factor: 3.240

5.  Mrassf1a-pap, a novel methylation-based assay for the detection of cell-free fetal DNA in maternal plasma.

Authors:  Jessica M E van den Oever; Sahila Balkassmi; Tim Segboer; E Joanne Verweij; Pieter A van der Velden; Dick Oepkes; Egbert Bakker; Elles M J Boon
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

Review 6.  Cell-free Fetal Nucleic Acid Identifier Markers in Maternal Circulation.

Authors:  Mahboubeh Ramezanzadeh; Sharifeh Khosravi; Rasoul Salehi
Journal:  Adv Biomed Res       Date:  2017-07-28

7.  Non-invasive prenatal diagnosis using cell-free fetal nucleic acids in maternal plasma: Progress overview beyond predictive and personalized diagnosis.

Authors:  Georgia Tounta; Aggeliki Kolialexi; Nikolas Papantoniou; George Th Tsangaris; Emmanuel Kanavakis; Ariadni Mavrou
Journal:  EPMA J       Date:  2011-05-17       Impact factor: 6.543

8.  Fetal RHD Genotyping Using Real-Time Polymerase Chain Reaction Analysis of Cell-Free Fetal DNA in Pregnancy of RhD Negative Women in South of Iran.

Authors:  Leili Moezzi; Zeinab Keshavarz; Reza Ranjbaran; Farzaneh Aboualizadeh; Abbas Behzad-Behbahani; Masooma Abdullahi; Amin Ramezani; Alamtaj Samsami; Sedigheh Sharifzadeh
Journal:  Int J Fertil Steril       Date:  2016-04-05

9.  Detection of cell-free foetal DNA fraction in female-foetus bearing pregnancies using X-chromosomal insertion/deletion polymorphisms examined by digital droplet PCR.

Authors:  Iveta Zednikova; Eva Pazourkova; Sona Lassakova; Barbora Vesela; Marie Korabecna
Journal:  Sci Rep       Date:  2020-11-18       Impact factor: 4.379
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.